CA2861477C - Sitaxentan derivative - Google Patents
Sitaxentan derivative Download PDFInfo
- Publication number
- CA2861477C CA2861477C CA2861477A CA2861477A CA2861477C CA 2861477 C CA2861477 C CA 2861477C CA 2861477 A CA2861477 A CA 2861477A CA 2861477 A CA2861477 A CA 2861477A CA 2861477 C CA2861477 C CA 2861477C
- Authority
- CA
- Canada
- Prior art keywords
- compound
- group
- reaction
- sitaxentan
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261592923P | 2012-01-31 | 2012-01-31 | |
| US61/592923 | 2012-01-31 | ||
| PCT/JP2013/051857 WO2013115162A1 (ja) | 2012-01-31 | 2013-01-29 | シタキセンタン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2861477A1 CA2861477A1 (en) | 2013-08-08 |
| CA2861477C true CA2861477C (en) | 2018-01-02 |
Family
ID=48870751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2861477A Active CA2861477C (en) | 2012-01-31 | 2013-01-29 | Sitaxentan derivative |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8592470B2 (enExample) |
| EP (1) | EP2810943B1 (enExample) |
| JP (1) | JP6144631B2 (enExample) |
| KR (1) | KR101933251B1 (enExample) |
| CN (1) | CN104039781B (enExample) |
| AR (1) | AR089838A1 (enExample) |
| AU (1) | AU2013216122B9 (enExample) |
| BR (1) | BR112014016204B1 (enExample) |
| CA (1) | CA2861477C (enExample) |
| ES (1) | ES2651293T3 (enExample) |
| IL (1) | IL233171A (enExample) |
| IN (1) | IN2014CN04945A (enExample) |
| MX (1) | MX358151B (enExample) |
| RU (1) | RU2622386C2 (enExample) |
| TW (1) | TW201336496A (enExample) |
| WO (1) | WO2013115162A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117255791B (zh) * | 2021-06-22 | 2026-06-19 | 亚克医药株式会社 | 化合物、内皮素a受体拮抗剂及医药组合物 |
| JP2025183466A (ja) * | 2022-11-11 | 2025-12-17 | 株式会社アークメディスン | 化合物、エンドセリンａ受容体拮抗剤、アンジオテンシンｉｉタイプ１受容体拮抗剤及び医薬組成物 |
| WO2024242594A1 (ru) * | 2023-05-23 | 2024-11-28 | Общество С Ограниченной Ответственностью "Ифар" | Средство для лечения легочных гипертензий |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861366A (en) | 1984-08-27 | 1989-08-29 | E. I. Du Pont De Nemours And Company | Herbicidal acetals and ketals |
| US4753672A (en) | 1985-07-16 | 1988-06-28 | E. I. Du Pont De Nemours And Company | Herbicidal acetals and ketals |
| US4659369A (en) | 1984-08-27 | 1987-04-21 | E. I. Du Pont De Nemours And Company | Herbicidal acetals and ketals |
| TW224462B (enExample) * | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
| EP0819125B1 (en) * | 1995-04-04 | 2003-06-18 | Texas Biotechnology Corporation | Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| SK9532002A3 (en) * | 1999-12-31 | 2003-06-03 | Texas Biotechnology Corp | Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US20060205733A1 (en) * | 2004-08-26 | 2006-09-14 | Encysive Pharmaceuticals | Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
| JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
| CA2683857A1 (en) * | 2007-04-10 | 2008-10-16 | Auspex Pharmaceuticals, Inc. | Substituted deuterium enriched thiophenes for the treatment of hypertension |
-
2013
- 2013-01-29 TW TW102103329A patent/TW201336496A/zh unknown
- 2013-01-29 WO PCT/JP2013/051857 patent/WO2013115162A1/ja not_active Ceased
- 2013-01-29 RU RU2014126427A patent/RU2622386C2/ru active
- 2013-01-29 EP EP13743422.1A patent/EP2810943B1/en active Active
- 2013-01-29 AR ARP130100263A patent/AR089838A1/es unknown
- 2013-01-29 ES ES13743422.1T patent/ES2651293T3/es active Active
- 2013-01-29 IN IN4945CHN2014 patent/IN2014CN04945A/en unknown
- 2013-01-29 CN CN201380005150.5A patent/CN104039781B/zh active Active
- 2013-01-29 US US13/752,660 patent/US8592470B2/en active Active
- 2013-01-29 JP JP2013556399A patent/JP6144631B2/ja active Active
- 2013-01-29 CA CA2861477A patent/CA2861477C/en active Active
- 2013-01-29 AU AU2013216122A patent/AU2013216122B9/en not_active Ceased
- 2013-01-29 BR BR112014016204-2A patent/BR112014016204B1/pt not_active IP Right Cessation
- 2013-01-29 MX MX2014007619A patent/MX358151B/es active IP Right Grant
- 2013-01-29 KR KR1020147021115A patent/KR101933251B1/ko active Active
-
2014
- 2014-06-16 IL IL233171A patent/IL233171A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014007619A (es) | 2014-09-15 |
| CN104039781B (zh) | 2016-08-17 |
| IL233171A (en) | 2017-07-31 |
| EP2810943B1 (en) | 2017-09-27 |
| EP2810943A1 (en) | 2014-12-10 |
| KR101933251B1 (ko) | 2018-12-27 |
| US8592470B2 (en) | 2013-11-26 |
| AU2013216122B2 (en) | 2016-12-08 |
| IL233171A0 (en) | 2014-07-31 |
| RU2622386C2 (ru) | 2017-06-15 |
| BR112014016204A2 (pt) | 2017-06-13 |
| WO2013115162A1 (ja) | 2013-08-08 |
| RU2014126427A (ru) | 2016-03-20 |
| AU2013216122B9 (en) | 2017-02-02 |
| AR089838A1 (es) | 2014-09-17 |
| JP6144631B2 (ja) | 2017-06-07 |
| CA2861477A1 (en) | 2013-08-08 |
| CN104039781A (zh) | 2014-09-10 |
| KR20140117455A (ko) | 2014-10-07 |
| BR112014016204B1 (pt) | 2020-09-24 |
| MX358151B (es) | 2018-08-07 |
| AU2013216122A1 (en) | 2014-07-24 |
| JPWO2013115162A1 (ja) | 2015-05-11 |
| IN2014CN04945A (enExample) | 2015-09-18 |
| US20130197045A1 (en) | 2013-08-01 |
| EP2810943A4 (en) | 2015-09-02 |
| ES2651293T3 (es) | 2018-01-25 |
| TW201336496A (zh) | 2013-09-16 |
| BR112014016204A8 (pt) | 2017-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1999111B1 (en) | Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists | |
| JP2024520969A (ja) | Ｗｅｅ１阻害剤とその用途 | |
| CA2434727A1 (en) | Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds | |
| WO2019154395A1 (zh) | 四氢异喹啉类化合物、其制备方法、包含此类化合物的药物组合物及其用途 | |
| AU2013216122B9 (en) | Sitaxsentan derivative | |
| CA2861479C (en) | Paroxetine derivative | |
| TW202440097A (zh) | 磺醯胺化合物、其藥物組合物和用途 | |
| UA112873C2 (uk) | Похідна піролідин-3-ілоцтової кислоти | |
| WO2013115167A1 (ja) | アムバチニブ誘導体 | |
| KR20250013195A (ko) | 신규 테트라히드로이소퀴놀린계 화합물, 이의 제조 방법, 테트라히드로이소퀴놀린계 화합물을 포함하는 약학적 조성물 및 이의 용도 | |
| JP2016003186A (ja) | フタラン環含有アデノシンａ２ａ受容体拮抗薬 | |
| RU2792034C2 (ru) | Тетрагидроизохинолиновое соединение, способ его получения, фармацевтическая композиция, содержащая такое соединение, и его применение | |
| AU2024417420A1 (en) | Biphenyl derivative, pharmaceutical composition and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160210 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250123 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250123 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250123 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD Year of fee payment: 13 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260120 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260120 |